Mbx biosciences doses first participant in phase 1 trial of mbx 4291 for the treatment of obesity

Preclinical data support the potential for improved weight loss and tolerability with once-monthly administration of mbx 4291 preclinical data support the potential for improved weight loss and tolerability with once-monthly administration of mbx 4291
MBX Ratings Summary
MBX Quant Ranking